Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

G alpha 12/13 basally regulates p53 through Mdm4 expression.

Mi-Sung Kim1, Sang Min Lee, Won Dong Kim

  • 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.

Molecular Cancer Research : MCR
|May 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation.

Cancer treatment and research communications·2026
Same author

FDFT1 Acts as a Negative Regulator of Autophagy by Modulating AMPK-ULK1 Signaling in Hepatocellular Carcinoma Cells.

Biomolecules & therapeutics·2026
Same author

Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production.

The Journal of clinical investigation·2026
Same author

Hyperglycemia in combination with excess fat intake promotes renal pyroptosis and fibrosis through Gα<sub>12</sub>-dependent endoplasmic reticulum stress.

Theranostics·2026
Same author

Recent Advances in Donepezil Delivery Systems via the Nose-to-Brain Pathway.

Pharmaceutics·2025
Same author

Anti-Inflammatory and Pain-Relieving Effects of Arnica Extract Hydrogel Patch in Carrageenan-Induced Inflammation and Hot Plate Pain Models.

Pharmaceutics·2025
Same journal

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Molecular cancer research : MCR·2026
Same journal

Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities.

Molecular cancer research : MCR·2026
Same journal

CELF2 is a tumor suppressor that modulates SLC7A11 and promotes ferroptosis in stomach adenocarcinoma.

Molecular cancer research : MCR·2026
Same journal

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Molecular cancer research : MCR·2026
Same journal

Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

Molecular cancer research : MCR·2026
Same journal

Mapping the Subtype-Specific PARP1 ADP-ribosylated Proteome in Breast Cancer Cells.

Molecular cancer research : MCR·2026
See all related articles

G alpha(12/13) proteins regulate basal p53 levels through mdm4, a key p53-stabilizing factor. This pathway is distinct from stress-induced p53 activation, highlighting a novel signaling mechanism.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • G alpha(12/13) proteins are involved in regulating cell proliferation and other physiological processes.
  • The tumor suppressor protein p53 plays a critical role in cell cycle control and apoptosis.
  • Mdm4 is a protein that stabilizes p53, thereby influencing its function.

Purpose of the Study:

  • To investigate the role of G alpha(12/13) in the regulation of p53 and its stabilizer, mdm4.
  • To elucidate the signaling pathway by which G alpha(12/13) influences p53 levels and activity.
  • To differentiate the G alpha(12/13)-mdm4-p53 pathway from stress-induced p53 activation.

Main Methods:

  • Immunoblotting and immunocytochemistry to assess protein levels and localization.

Related Experiment Videos

  • Analysis of p53 DNA binding activity.
  • Gene silencing (small interfering RNA) and overexpression studies.
  • Treatment with genotoxic agents (doxorubicin, etoposide) and proteasomal inhibitors.
  • Use of constitutively active G alpha(12/13) mutants.

    • Main Results:

    • G alpha(12) deficiency decreased p53 levels and DNA binding activity, repressed p21, and induced Bcl(2).
    • G alpha(12) deficiency repressed mdm4, a p53-stabilizing protein, suggesting G alpha(12) involvement in p53 stabilization.
    • Constitutively active G alpha(12) or G alpha(13) promoted p53 accumulation and mdm4 induction.
    • Mdm4 overexpression, but not p53 overexpression, led to p53 accumulation, confirming mdm4's regulatory role downstream of G alpha(12/13).
    • Genotoxic stress induced p53 accumulation but did not induce mdm4 in G alpha(12/13)-deficient cells, and G alpha(12/13) activation did not phosphorylate p53.

    Conclusions:

    • G alpha(12/13) proteins regulate basal p53 levels primarily through the induction of mdm4.
    • This G alpha(12/13)-mdm4-p53 signaling axis is distinct from the p53 activation pathways triggered by genotoxic stress.
    • The findings reveal a novel mechanism controlling p53 stability and function, with implications for understanding cell proliferation and cancer biology.